AML can develop de novo or from an antecedent diagnosis of myelodysplastic syndrome (MDS) or myeloproliferative neoplasm
doi: 10.3389/fphys.2025.1651151 Received 20 June 2025 Revised 17 October 2025 Accepted 23 October 2025 Published 16 December 2025 Volume 16 - 2025 Edited by Geoffrey A
Physiol Rev (2014) 94(2):32954
Cascone T, Weissferdt A, Godoy MCB, William WN Jr, Leung CH, Lin HY, Basu S, Yadav SS, Pataer A, Mitchell KG, Khan MAW, Shi Y, Haymaker C, Solis LM, Parra ER, Kadara H, Wistuba II, Sharma P, Allison JP, Ajami NJ, Wargo JA, Jenq RR, Gibbons DL, Lee JJ, Swisher SG , Vaporciyan AA, Heymach JV, Sepesi B
After 24 h, cells were stained with C11-BODIPY, and relative green and red fluorescence was determined (n = 6 technical replicates from 2 independent experiments